Seroepidemiological Prevalence of Helicobacter pylori in the south of Tehran, Iran

Background: Helicobacter pylori (HP) is one of the most widespread infections in the world especially in developing countries such as Iran. Evaluation of disease in Tehran, the capital of Iran, is serious due to overpopulation and also some lacks in sanitary facilities and economic conditions.Object...

Full description

Bibliographic Details
Main Authors: Reza Torabi, Hamid Tebyanian, Mohamad Heiat, Ali Choopani
Format: Article
Language:English
Published: Sadra Danesh Negar 2022-01-01
Series:Novelty in Clinical Medicine
Subjects:
Online Access:https://www.nclinmed.com/article_140810_33dcf8a3396b67a5e9242894abb4ed6e.pdf
_version_ 1797328324927684608
author Reza Torabi
Hamid Tebyanian
Mohamad Heiat
Ali Choopani
author_facet Reza Torabi
Hamid Tebyanian
Mohamad Heiat
Ali Choopani
author_sort Reza Torabi
collection DOAJ
description Background: Helicobacter pylori (HP) is one of the most widespread infections in the world especially in developing countries such as Iran. Evaluation of disease in Tehran, the capital of Iran, is serious due to overpopulation and also some lacks in sanitary facilities and economic conditions.Objectives: The aim of this study is the evaluation of anti-HP antibodies in patients referred to a clinical lab in Tehran, Iran in 2019.Methods: We evaluated anti-HP IgA and IgG antibodies by ELISA method. Positive and negative results were analyzed. During this study, the total number of 593 patients that were referred to the clinical laboratories due to symptoms of the disease was examined. Serum samples of these patients were collected and used for diagnosis via ELISA kit. Data were analyzed using SPSSv.17 through Kendall's tau-b test.Results: From 593 patients, 451 have positive titer for both antibodies. In addition, 87% of patients have positive titer for IgG and 47.8% were positive for IgA titer. Findings also demonstrated that between the age groups, patients above 70 years old had the highest percentage of positive results for IgG titer (90%), and age-groups with 50-60 years old had the highest percentage of positive results for IgA titer (82%). Differences between genders were not statistically significant.Conclusion: It seems that the number of patients suffering from this disease is rising in Tehran and even the lower age- groups are associated with this disease. For a reliable diagnosis, evaluation of both antibodies is recommended.
first_indexed 2024-03-08T06:50:12Z
format Article
id doaj.art-814d137b15384273bf0a8fb12a51842a
institution Directory Open Access Journal
issn 2783-4492
language English
last_indexed 2024-03-08T06:50:12Z
publishDate 2022-01-01
publisher Sadra Danesh Negar
record_format Article
series Novelty in Clinical Medicine
spelling doaj.art-814d137b15384273bf0a8fb12a51842a2024-02-03T07:16:57ZengSadra Danesh NegarNovelty in Clinical Medicine2783-44922022-01-0111555810.22034/ncm.2022.140810140810Seroepidemiological Prevalence of Helicobacter pylori in the south of Tehran, IranReza Torabi0Hamid Tebyanian1Mohamad Heiat2Ali Choopani3Molecular Biology Research Center, Baqiyatallah University of Medical Sciences, Tehran, IranResearch Center for Prevention of Oral and Dental Diseases, Baqiyatallah University of Medical Sciences, Tehran, IranResearch Center for Gastroenterology and Liver Diseases, Baqiyatallah University of Medical Sciences, Tehran, IranAmiran Oghyanoos Biotechnology Company, Tehran, IranBackground: Helicobacter pylori (HP) is one of the most widespread infections in the world especially in developing countries such as Iran. Evaluation of disease in Tehran, the capital of Iran, is serious due to overpopulation and also some lacks in sanitary facilities and economic conditions.Objectives: The aim of this study is the evaluation of anti-HP antibodies in patients referred to a clinical lab in Tehran, Iran in 2019.Methods: We evaluated anti-HP IgA and IgG antibodies by ELISA method. Positive and negative results were analyzed. During this study, the total number of 593 patients that were referred to the clinical laboratories due to symptoms of the disease was examined. Serum samples of these patients were collected and used for diagnosis via ELISA kit. Data were analyzed using SPSSv.17 through Kendall's tau-b test.Results: From 593 patients, 451 have positive titer for both antibodies. In addition, 87% of patients have positive titer for IgG and 47.8% were positive for IgA titer. Findings also demonstrated that between the age groups, patients above 70 years old had the highest percentage of positive results for IgG titer (90%), and age-groups with 50-60 years old had the highest percentage of positive results for IgA titer (82%). Differences between genders were not statistically significant.Conclusion: It seems that the number of patients suffering from this disease is rising in Tehran and even the lower age- groups are associated with this disease. For a reliable diagnosis, evaluation of both antibodies is recommended.https://www.nclinmed.com/article_140810_33dcf8a3396b67a5e9242894abb4ed6e.pdfantibodyelisaepidemiologyhelicobacter pylori
spellingShingle Reza Torabi
Hamid Tebyanian
Mohamad Heiat
Ali Choopani
Seroepidemiological Prevalence of Helicobacter pylori in the south of Tehran, Iran
Novelty in Clinical Medicine
antibody
elisa
epidemiology
helicobacter pylori
title Seroepidemiological Prevalence of Helicobacter pylori in the south of Tehran, Iran
title_full Seroepidemiological Prevalence of Helicobacter pylori in the south of Tehran, Iran
title_fullStr Seroepidemiological Prevalence of Helicobacter pylori in the south of Tehran, Iran
title_full_unstemmed Seroepidemiological Prevalence of Helicobacter pylori in the south of Tehran, Iran
title_short Seroepidemiological Prevalence of Helicobacter pylori in the south of Tehran, Iran
title_sort seroepidemiological prevalence of helicobacter pylori in the south of tehran iran
topic antibody
elisa
epidemiology
helicobacter pylori
url https://www.nclinmed.com/article_140810_33dcf8a3396b67a5e9242894abb4ed6e.pdf
work_keys_str_mv AT rezatorabi seroepidemiologicalprevalenceofhelicobacterpyloriinthesouthoftehraniran
AT hamidtebyanian seroepidemiologicalprevalenceofhelicobacterpyloriinthesouthoftehraniran
AT mohamadheiat seroepidemiologicalprevalenceofhelicobacterpyloriinthesouthoftehraniran
AT alichoopani seroepidemiologicalprevalenceofhelicobacterpyloriinthesouthoftehraniran